Usefulness of Right Ventricular Dysfunction to Predict New-Onset Atrial Fibrillation Following Coronary Artery Bypass Grafting

Usefulness of Right Ventricular Dysfunction to Predict New-Onset Atrial Fibrillation Following Coronary Artery Bypass Grafting

Accepted Manuscript Usefulness of Right Ventricular Dysfunction to Predict New-Onset Atrial Fibrillation Following Coronary Artery Bypass Grafting Avi...

224KB Sizes 3 Downloads 37 Views

Accepted Manuscript Usefulness of Right Ventricular Dysfunction to Predict New-Onset Atrial Fibrillation Following Coronary Artery Bypass Grafting Avi Shimony, MD Jonathan Afilalo, MD, MSc Aidan W. Flynn, MD, PhD David Langleben, MD Arvin K. Agnihotri, MD Jean-Francois Morin, MD David M. Shahian, MD Michael H. Picard, MD Lawrence G. Rudski, MD PII:

S0002-9149(13)02447-8

DOI:

10.1016/j.amjcard.2013.11.048

Reference:

AJC 20159

To appear in:

The American Journal of Cardiology

Received Date: 21 September 2013 Revised Date:

11 November 2013

Accepted Date: 18 November 2013

Please cite this article as: Shimony A, Afilalo J, Flynn AW, Langleben D, Agnihotri AK, Morin J-F, Shahian DM, Picard MH, Rudski LG, Usefulness of Right Ventricular Dysfunction to Predict New-Onset Atrial Fibrillation Following Coronary Artery Bypass Grafting, The American Journal of Cardiology (2014), doi: 10.1016/j.amjcard.2013.11.048. This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

ACCEPTED MANUSCRIPT 1

Usefulness of Right Ventricular Dysfunction to Predict New-Onset Atrial Fibrillation Following Coronary Artery Bypass Grafting

RI PT

Running title: Post Coronary Artery Bypass Atrial Fibrillation Avi Shimony, M.D. a*, Jonathan Afilalo M.D. M.Sc. a,b*, Aidan W. Flynn M.D. Ph.D. b, David Langleben M.D. a, Arvin K. Agnihotri M.D. c, Jean-Francois Morin M.D. d, David M. Shahian M.D. c,e, Michael H. Picard M.D. b, Lawrence G. Rudski M.D. a a

M AN U

SC

Division of Cardiology, Jewish General Hospital, Lady Davis Institute for Medical Research, McGill University, Montreal, QC, Canada; b Cardiac Ultrasound Laboratory, Division of Cardiology, Massachusetts General Hospital, Harvard University, Boston, Massachusetts, USA; c Division of Cardiac Surgery, Massachusetts General Hospital, Harvard University, Boston, Massachusetts, USA; d Division of Cardiac Surgery, Jewish General Hospital, Lady Davis Institute for Medical Research, McGill University, Montreal, QC, Canada; e Department of Surgery and Center for Quality and Safety, Massachusetts General Hospital, Harvard University, Boston, Massachusetts, USA

EP

TE D

Address for Correspondence Lawrence G. Rudski, M.D. Associate Professor of Medicine, McGill University Director, Noninvasive Cardiology Division of Cardiology, Jewish General Hospital 3755 Cote Ste Catherine Rd Montreal, QC H3T 1E2 Telephone: (514) 340-7531 / Fax: (514) 340-7534 Email: [email protected]

AC C

The first two authors contributed equally to this paper (*). This work was conducted with support from Harvard Catalyst | The Harvard Clinical and Translational Science Center (NIH Award #UL1 RR 025758 and financial contributions from Harvard University and its affiliated academic health care centers). The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic health care centers, the National Center for Research Resources, or the National Institutes of Health. Conflicts of interest for all authors: None

ACCEPTED MANUSCRIPT 2

ABSTRACT Post-operative atrial fibrillation (AF) is a serious yet common complication after

RI PT

coronary artery bypass grafting surgery (CABG). Risk factors for post-operative AF have been identified, including echocardiographic parameters, and these are relied upon to

implement preventative strategies that reduce the incidence of AF. There has yet to be a

SC

study examining the impact of echocardiographic right heart parameters for the

prediction of post-operative AF. Thus, a panel of right heart parameters was measured in

M AN U

a cohort of patients undergoing isolated CABG, excluding those who did not have echocardiographic assessment within 30 days before surgery and those with any prior history of AF. The primary outcome was post-operative AF defined as any episode of AF requiring treatment during the index hospitalization. Post-operative AF occurred in 197 of 768 patients (25.6%); these were older and more likely to have hypertension and

TE D

chronic kidney disease. After adjustment for clinical and echocardiographic variables, left atrial volume index ≥34 mL/m2 (OR 1.98, 95% CI 1.36 to 2.87), abnormal right

EP

ventricular myocardial performance index (RV-MPI) (OR 1.50 95% CI 1.01 to 2.24), and advancing age (OR 1.05, 95% CI 1.03 to 1.07) were found to be independent predictors

AC C

of post-operative AF. In conclusion, RV-MPI is a novel predictor of post-operative AF in patients undergoing isolated CABG and appears to be additive to established risk factors such as age and left atrial volume.

Key words: Post-operative atrial fibrillation; coronary artery bypass graft surgery; right ventricular myocardial performance index

ACCEPTED MANUSCRIPT 3

INTRODUCTION Post-operative atrial fibrillation (AF) is a serious yet common complication after

RI PT

coronary artery bypass grafting surgery (CABG). Risk factors for post-operative AF have been identified and are relied upon by clinicians to implement preventative strategies that have been shown to reduce the incidence of AF. To date, echocardiographic risk factors

SC

have been restricted to left heart parameters such as left atrial volume and left ventricular function. There has not yet been a study examining the impact of echocardiographic right

M AN U

heart parameters on the development of post-operative AF. Using the Pre-Operative Surgical Stratification by Echocardiography (POSSE) database (1), we hypothesized that echocardiographic right heart parameters would provide additive prognostic value to predict the occurrence of postoperative AF.

TE D

METHODS

Consecutive patients undergoing isolated CABG without concomitant repair or

EP

replacement of the heart valves or great vessels were identified within the POSEE database. Data were obtained from two university-affiliated hospitals in the United States

AC C

(Massachusetts General Hospital, Boston, MA, January 1 2007 to December 31 2009) and Canada (Jewish General Hospital, Montreal, QC, September 1 2010 to July 11 2011). From this cohort, subjects who had a digitally available preoperative echocardiogram within 30 days before surgery were eligible for inclusion (n=854). Subjects who had any prior history of AF were excluded (Figure 1). The study protocol was approved by the institutional review boards of both hospitals.

ACCEPTED MANUSCRIPT 4

Demographic data, preoperative clinical variables, operative variables, and postoperative in-hospital outcomes were extracted from the Society of Thoracic Surgeons

RI PT

(STS) Adult Cardiac Surgery Database (2) at the Massachusetts General Hospital and from electronic medical records using identical data definitions at the Jewish General

Hospital. These covariates included but were not limited to: age, sex, body mass index,

SC

prior AF, supraventricular arrhythmia, ventricular arrhythmia, prior myocardial

infarction, diabetes, hypertension, dyslipidemia, chronic kidney disease, chronic lung

M AN U

disease, peripheral arterial disease, cerebrovascular disease, preoperative creatinine, preoperative medications, prior cardiac surgery and/or percutaneous coronary intervention, cardiac presentation, cardiogenic shock, intra-aortic balloon pump use, number of diseased coronary vessels, number of grafts, and whether the operation was elective or urgent/emergent.

TE D

Echocardiographic parameters were re-measured offline from the digital echocardiograms by independent echocardiography-trained cardiologists who were

EP

blinded to the study outcomes. Disagreements were resolved by consensus and/or a third senior observer. These parameters encompassed left and right-sided chamber size,

AC C

geometry, systolic function, diastolic function, as well as valvular regurgitation and stenosis. All were measured and classified according to the American Society of Echocardiography guidelines (3-7). Right and left atrial areas were traced at end-systole in the apical 4-chamber view.

RV endocardial borders were traced at end-diastole and end-systole in apical 4-chamber view. The RV fractional area change (FAC), a measure of RV systolic function, was calculated by the following formula: [(RV end-diastolic area – RV end-systolic area) /

ACCEPTED MANUSCRIPT 5

RV end-diastolic area] x 100. RV myocardial performance index (MPI), a measure of systolic and diastolic function, was measured by either the pulsed Doppler method or the

RI PT

tissue Doppler method and calculated using the following formula: [(tricuspid closure opening time – ejection time) / ejection time], using a cutoff of 0.40 for both methods (3). Pulmonary artery systolic pressure (PASP) was estimated using peak tricuspid

SC

regurgitation jet velocity with 10 mmHg added for right atrial pressure. LV mass was measured using the Devereux method and indexed to body surface area. LV ejection

M AN U

fraction (EF) was measured using the biplane Simpson’s method. Several parameters including pulsed Doppler of the mitral and pulmonary vein inflow and tissue Doppler septal and lateral mitral annulus early diastolic velocities were integrated to determine LV diastolic function. The degree of valvular regurgitation and stenosis were assessed using a multi-parametric approach according to ASE guidelines. Significant valvular

TE D

regurgitation was defined as at least moderate in severity. Echocardiograms were performed with GE Vivid 7 or GE vivid E9 machines and

EP

interpreted on EchoPAC workstations (GE Healthcare, Milwaukee, WI) at the Jewish General Hospital and with the Philips IE33, Sonos 7500 and Xcelera workstations

AC C

(Philips Healthcare, Andover, MA) or GE Vivid 7 machines and EchoPAC workstation (GE Healthcare, Milwaukee, WI) at the Massachusetts General Hospital. Patients were monitored by continuous telemetry for at least 72-96 hours after

surgery and by 12-lead electrocardiograms performed on a routine daily basis and when indicated due to clinical signs. AF was recognized universally as a supraventricualr arrhythmia with an irregularly irregular ventricular rhythm. The primary endpoint of this study was post-operative AF defined by the STS as an episode of AF of any duration

ACCEPTED MANUSCRIPT 6

diagnosed by the attending physician that occurred during the in-hospital postoperative period and required treatment (medical therapy and/or electrical cardioversion). The

RI PT

decision to treat a patient for atrial fibrillation was at the discretion of the attending physician. Postoperative in-hospital outcomes other than post-operative AF included death from any cause, stroke, acute renal failure, prolonged intubation, the need of

SC

reoperation, and postoperative length of stay.

Continuous variables were reported as mean ± standard deviation (SD) and

M AN U

compared using a two-tailed Student’s t-test. Categorical variables were reported as proportions and compared using a chi-square or Fisher’s exact test where appropriate. Demographic, clinical, and echocardiographic variables were entered in a multivariable logistic regression model. The Akaike’s Information Criterion (AIC) was used to select the optimal model (lowest AIC) to predict post-operative AF. STATA 12 (Stata-Corp,

TE D

College Station TX, USA) was used to conduct analyses.

EP

RESULTS

The study population consisted of 768 patients (21.6% female), of which 197

AC C

(25.6%) developed post-operative AF. No patient was lost to follow-up for the primary outcome measure. Patients who developed post-operative AF were older (mean age 71.3 vs. 64.9, p<0.001) and had a significantly higher rate of hypertension, chronic kidney disease, and congestive heart failure. They had slightly more diseased vessels and longer cardiopulmonary bypass times than patients without post-operative AF. There were no other notable differences between groups in baseline characteristics (Table 1).

ACCEPTED MANUSCRIPT 7

The composite outcome of in-hospital mortality and major morbidity was significantly higher in the post-operative AF group (23.9% vs. 10.9%, p<0.001). With

RI PT

respect to individual outcomes, mortality, renal failure, and prolonged intubation rates were significantly higher in the post-operative AF group; stroke and reoperation rates

tended to be higher in the post-operative AF group although these outcomes did not reach

SC

statistical significance. In addition, patients with post-operative AF remained in hospital 5.0 days longer on average.

M AN U

Echocardiographic variables for patients with and without post-operative AF are shown in Table 2. With respect to right-sided parameters, patients who developed postoperative AF had larger right atrial size, worse RV-MPI, worse tricuspid regurgitation severity, higher pulmonary artery systolic pressure, and no difference in RV-FAC. With Patients who developed post-operative AF had larger left atrial size, larger LV end-

TE D

diastolic volume and mass, and lower LVEF. Furthermore, they were more likely to have LV diastolic dysfunction and moderate mitral regurgitation. There were no cases of

EP

severe mitral or tricuspid regurgitation (given the isolated CABG cohort that did not undergo any valve procedures).

AC C

After adjustment for clinical and echocardiographic variables (Table 3), the optimal multivariable model to predict post-operative AF was found to include the following variables: left atrial volume index ≥34 mL/m2 (odd ratio [OR] 1.98, 95% confidence interval [CI] 1.36 to 2.87), abnormal RV-MPI (OR 1.50, 95% CI 1.01 to 2.24), and advancing age (OR 1.05 per year, 95% CI 1.03 to 1.07). Sensitivity analysis adjusting for preoperative medication use did not alter the results.

ACCEPTED MANUSCRIPT 8

DISCUSSION The present study has demonstrated that echocardiographic right ventricular

RI PT

performance is predictive of post-operative AF in patients undergoing isolated CABG. In particular, RV-MPI, a composite measure of RV systolic and diastolic function, was

additive to traditional risk factors for predicting post-operative AF (3). AF is one of the

SC

most commonly occurring arrhythmias after cardiac surgery and is associated with

significant morbidity and mortality (8). In the general population, the pathophysiology of

M AN U

AF has been extensively studied yet remains incompletely understood (9). Similarly, in the context of cardiac surgery, numerous risk factors for post-operative AF have been identified, but the pathophysiology of this entity is still to a large extent elusive (10-14). Right-sided cardiac dysfunction has been linked to AF and supraventricular tachycardia in other settings (15-17). Aziz et al. determined the incidence and predictors

TE D

of AF in 904 patients who were admitted with decompensated heart failure (15). AF developed in 21% of these patients, with a higher incidence among those with RV

EP

dysfunction (39% vs. 12%). RV dysfunction was found to be the strongest independent predictor for the development of AF (OR 4.45, 95% CI 2.98 to 6.65). In a study of

AC C

patients undergoing elective lung resection by Matyal et al., left atrial dilation, abnormal RV-MPI, and advanced age were identified as independent predictors of postoperative supraventricular tachycardia (17). Bouchardy et al. demonstrated that right atrial dilatation had a significant impact on the development of AF in adult patients with congenital heart disease patients who had right-sided cardiac pathologies (16). In their multivariable analysis, age (OR 1.07, 95% CI 1.04 to 1.1), left atrial area (OR 1.15, 95% CI 1.06 to 1.26), and right atrial area (OR 1.08, 95% CI 1.01 to 1.16) were significantly

ACCEPTED MANUSCRIPT 9

associated with AF. Interestingly, in a study of anesthetized lambs undergoing thoracic surgery, structural and functional changes that caused alterations in RV function were

RI PT

implicated in the genesis of postoperative supraventricular tachycardia (18). Our study is therefore consistent with the observation that RV function is relevant to the development of AF and extends this finding to the post-operative cardiac surgery patient.

SC

Most measures of right-sided cardiac function reflect systolic performance. AF is classically seen in the context of atrial dilation and may therefore be associated with

M AN U

abnormal diastolic function. In our study, RV FAC, a measure of RV systolic-only function, did not predict post-operative AF. Conversely, RV MPI, which is a measure of systolic and diastolic function, did predict post-operative AF; underscoring the importance of global right heart function as changes in both the atrium and ventricle may contribute to the pathogenesis of AF. It remains to be seen histologically whether

TE D

abnormalities in RV-MPI are associated with pro-arrhythmic changes in the anatomic structure of the right atrium.

EP

A number of pathophysiological mechanisms may be postulated for AF emanating from the right heart in post-operative patients. Firstly, C-reactive protein, a

AC C

marker of chronic inflammation, has been implicated as a risk factor for post-operative AF in both on-pump and off-pump bypass surgery (19). Similarly, C-reactive protein, IL6, and TNF-α have been implicated as risk factors for abnormal RV-MPI (20). This shared association may reflect an epiphenomenon rather than a causal link. Secondly, RV dysfunction may lead to circulatory failure, peri-operative fluid overload, myocardial ischemia, hypoxemia, and increased sympathetic activity after cardiac surgery (21-23). These in turn have been associated with AF (24-26). Thirdly, vasopressors are more often

ACCEPTED MANUSCRIPT 10

required postoperatively in patients with RV dysfunction (27). High dose inotropic support was reported as an independent predictor of post-operative AF following elective

RI PT

CABG (24). Finally, RV dysfunction may lead to right atrial dilation and remodeling which may alter atrial refractoriness and conduction and increase susceptibility to postoperative AF (9, 28).

SC

Our study has several potential limitations. First, since it is a retrospective study, general reservations pertaining to potential confounders and biases should be

M AN U

acknowledged. Second, we may have not have captured episodes of post-operative AF since systematic continuous telemetry was limited to the first 72-96 hours after surgery and not throughout the entire hospitalization. However, it is unlikely that this would have a major impact on our analysis since the vast majority of post-operative AF episodes are known to occur during the first 48-72 hours after surgery (11, 29-30). Third, we did not

TE D

have access to postoperative medication usage within our data sources, and we could not ascertain the protective/negative effects of antiarrhythmic drugs. Finally, we have

EP

confined our analysis to patients undergoing isolated CABG which limits a wider

AC C

generalizability of the findings to patients undergoing other types of cardiac surgery.

ACKNOWLEDGMENTS We would like to thank Marcia Leavitt, David Crowell, and Karen Lynch for their

invaluable help in obtaining clinical and echocardiographic data for this study. We would also like to thank all of the cardiac sonographers at the Massachusetts General Hospital and Jewish General Hospital for their excellence in acquiring the echocardiographic images that made this study possible.

ACCEPTED MANUSCRIPT 11

1. Afilalo J, Flynn AW, Shimony A, Rudski LG, Agnihotri AK, Morin JF, Castrillo C, Shahian DM, Picard MH. Incremental value of the preoperative

RI PT

echocardiogram to predict mortality and major morbidity after coronary artery bypass surgery. Circulation 2013; 127:356-364

2. Shahian DM, O'Brien SM, Filardo G, Ferraris VA, Haan CK, Rich JB, Normand

SC

SL, DeLong ER, Shewan CM, Dokholyan RS, Peterson ED, Edwards FH,

Anderson RP; Society of Thoracic Surgeons Quality Measurement Task Force.

M AN U

The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1-coronary artery bypass grafting surgery. Ann Thorac Surg 2009; 88:S2-S22 3. Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, Solomon SD, Louie EK, Schiller NB. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of

TE D

Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian

EP

Society of Echocardiography. J Am Soc Echocardiogr 2010; 23:685-713. 4. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA,

AC C

Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ; Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of

ACCEPTED MANUSCRIPT 12

the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18:14401463.

RI PT

5. Baumgartner H, Hung J, Bermejo J, Chambers JB, Evangelista A, Griffin BP, Iung B, Otto CM, Pellikka PA, Quiñones M; American Society of Echocardiography; European Association of Echocardiography.

SC

Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. J Am Soc Echocardiogr 2009; 22:1-23; [Erratum in J Am Soc

M AN U

Echocardiogr 2009; 22:442].

6. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, Waggoner AD, Flachskampf FA, Pellikka PA, Evangelista A. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 2009; 22: 107-133.

TE D

7. Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA, Nihoyannopoulos P, Otto CM, Quinones MA, Rakowski H, Stewart WJ,

EP

Waggoner A, Weissman NJ; American Society of Echocardiography. Recommendations for evaluation of the severity of native valvular regurgitation

AC C

with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 2003; 16: 777-802.

8. Echahidi N, Pibarot P, O'Hara G, Mathieu P. Mechanisms, prevention, and treatment of atrial fibrillation after cardiac surgery. J Am Coll Cardiol 2008; 51:793-801. 9. Iwasaki YK, Nishida K, Kato T, Nattel S. Atrial fibrillation pathophysiology: implications for management. Circulation 2011;124: 264-274.

ACCEPTED MANUSCRIPT 13

10. Aranki SF, Shaw DP, Adams DH, Rizzo RJ, Couper GS, VanderVliet M, Collins JJ Jr, Cohn LH, Burstin HR. Predictors of atrial fibrillation after coronary artery

RI PT

surgery. Current trends and impact on hospital resources. Circulation 1996; 94: 390-397.

11. Maesen B, Nijs J, Maessen J, Allessie M, Schotten U. Post-operative atrial

SC

fibrillation: a maze of mechanisms. Europace 2012; 14:159-174.

12. Creswell LL, Schuessler RB, Rosenbloom M, Cox JL. Hazards of postoperative

M AN U

atrial arrhythmias. Ann Thorac Surg 1993;56:539–549

13. Haffajee JA, Lee Y, Alsheikh-Ali AA, Kuvin JT, Pandian NG, Patel AR. Preoperative left atrial mechanical function predicts risk of atrial fibrillation following cardiac surgery. JACC Cardiovasc Imaging 2011; 4:833-840. 14. Melduni RM, Suri RM, Seward JB, Bailey KR, Ammash NM, Oh JK, Schaff HV,

TE D

Gersh BJ. Diastolic dysfunction in patients undergoing cardiac surgery: a pathophysiological mechanism underlying the initiation of new-onset post-

EP

operative atrial fibrillation. J Am Coll Cardiol 2011; 58:953-961. 15. Aziz EF, Kukin M, Javed F, Musat D, Nader A, Pratap B, Shah A, Enciso JS,

AC C

Chaudhry FA, Herzog E. Right ventricular dysfunction is a strong predictor of developing atrial fibrillation in acutely decompensated heart failure patients, ACAP-HF data analysis. J Card Fail 2010; 16:827- 834.

16. Bouchardy J, Marelli AJ, Martucci G, Bottega N, Therrien J. Mirror image atrial dilatation in adult patients with atrial fibrillation and congenital heart disease. Int J Cardiol 2013; 167:816-820

ACCEPTED MANUSCRIPT 14

17. Matyal R, Mahmood F, Hess P, Zhao X, Mitchell J, Maslow A, Gangadharan S, Decamp M. Right ventricular echocardiographic predictors of postoperative

RI PT

supraventricular arrhythmias after thoracic surgery: a pilot study. Ann Thorac Surg 2010; 90: 1080-1086.

18. Chen RL, Penny DJ, Greve G, Lab MJ. Stretch-induced regional mechanoelectric

SC

dispersion and arrhythmia in the right ventricle of anesthetized lambs. Am J Physiol Heart Circ Physiol 2004; 286: H1008-1014.

M AN U

19. Lo B, Fijnheer R, Nierich AP, Bruins P, Kalkman CJ. C-reactive protein is a risk indicator for atrial fibrillation after myocardial revascularization. Ann Thorac Surg 2005; 79: 1530-1535.

20. Marfella R, Esposito K, Siniscalchi M, Cacciapuoti F, Giugliano F, Labriola D, Ciotola M, Di Palo C, Misso L, Giugliano D. Effect of weight loss on cardiac

TE D

synchronization and proinflammatory cytokines in premenopausal obese women. Diabetes Care 2004; 27: 47-52.

EP

21. Haddad F, Couture P, Tousignant C, Denault AY. The right ventricle in cardiac surgery, a perioperative perspective: II. Pathophysiology, clinical importance, and

AC C

management. Anesth Analg 2009; 108: 422-433. 22. Haddad F, Doyle R, Murphy DJ, Hunt SA. Right ventricular function in cardiovascular disease, part II: pathophysiology, clinical importance, and management of right ventricular failure. Circulation 2008; 117: 1717-1731

23. Haddad F, Denault AY, Couture P, Cartier R, Pellerin M, Levesque S, Lambert J, Tardif JC. Right ventricular myocardial performance index predicts perioperative

ACCEPTED MANUSCRIPT 15

mortality or circulatory failure in high-risk valvular surgery. J Am Soc Echocardiogr 2007; 20: 1065-1072.

RI PT

24. Koletsis EN, Prokakis C, Crockett JR, Dedeilias P, Panagiotou M, Panagopoulos N, Anastasiou N, Dougenis D, Apostolakis E. Prognostic factors of atrial

fibrillation following elective coronary artery bypass grafting: the impact of

SC

quantified intraoperative myocardial ischemia. J Cardiothorac Surg 2011; 6:127. 25. Kalus JS, Caron MF, White CM, Mather JF, Gallagher R, Boden WE, Kluger J.

M AN U

Impact of fluid balance on incidence of atrial fibrillation after cardiothoracic surgery. Am J Cardiol 2004; 94: 1423-1425

26. Park HW, Shen MJ, Lin SF, Fishbein MC, Chen LS, Chen PS. Neural mechanisms of atrial fibrillation. Curr Opin Cardiol 2012; 27: 24-28. 27. Maslow AD, Regan MM, Panzica P, Heindel S, Mashikian J, Comunale ME.

TE D

Precardiopulmonary bypass right ventricular function is associated with poor outcome after coronary artery bypass grafting in patients with severe left

EP

ventricular systolic dysfunction. Anesth Analg 2002; 95: 1507-1518. 28. Mariscalco G, Engström KG, Ferrarese S, Cozzi G, Bruno VD, Sessa F, Sala A.

AC C

Relationship between atrial histopathology and atrial fibrillation after coronary bypass surgery. J Thorac Cardiovasc Surg 2006; 131: 1364-1372.

29. Almassi GH, Pecsi SA, Collins JF, Shroyer AL, Zenati MA, Grover FL. Predictors and impact of postoperative atrial fibrillation on patients' outcomes: a report from the Randomized on Versus off Bypass trial. Error! Hyperlink reference not valid. 2012; 143:93-102.

ACCEPTED MANUSCRIPT 16

30. Osranek M, Fatema K, Qaddoura F, Al-Saileek A, Barnes ME, Bailey KR, Gersh BJ, Tsang TS, Zehr KJ, Seward JB Left atrial volume predicts the risk of atrial

RI PT

fibrillation after cardiac surgery: a prospective study. J Am Coll Cardiol 2006;

AC C

EP

TE D

M AN U

SC

48:779-786.

ACCEPTED MANUSCRIPT 17

FIGURE LEGEND

AC C

EP

TE D

M AN U

SC

RI PT

Figure 1: Flow Diagram

ACCEPTED MANUSCRIPT 1

Table 1: Baseline Characteristics

AC C

EP

P-value

RI PT

SC

TE D

Age (years) Female Body mass index (kg/m2) Obesity Hypertension Dyslipidemia Diabetes mellitus Chronic kidney disease Preoperative creatinine (mg/dL) Preoperative creatinine clearance Chronic lung disease Peripheral arterial disease Prior cerebrovascular disease Prior stroke Myocardial infarction Urgent/Emergent operative status Heart failure within 2 weeks Number of diseased vessels Cardiopulmonary bypass time Preoperative medication use ACE inhibitors Beta-blockers Statin Inotropes In-hospital outcomes Mortality or major morbidity Mortality Stroke Renal failure Prolonged intubation >24 hours Need for reoperation Postoperative length of stay (days)

Post Operative Atrial Fibrillation No Yes (N=571) (N=197) 64.9 ± 11.0 71.3 ± 9.9 125 (21.9%) 41 (20.8%) 28.5 ± 4.8 28.5 ± 5.1 185 (32.4%) 65 (33.0%) 443 (77.6%) 172 (87.3%) 281 (49.2%) 88 (44.7%) 215 (37.7%) 71 (36.0%) 169 (29.6%) 93 (47.2%) 1.22 ± 0.73 1.26 ± 0.44 80.0 ± 32.9 69.5 ± 34.7 55 (9.6%) 19 (9.6%) 83 (14.6%) 35 (17.8%) 86 (15.1%) 39 (19.9%) 48 (8.4%) 13 (6.6%) 236 (41.4%) 82 (41.6%) 485 (84.9%) 168 (85.3%) 129 (22.8%) 59 (30.6%) 3.5 ± 0.6 3.6 ± 0.6 121.1 ± 38.7 135.7 ± 52.4

M AN U

Variable

<0.001 0.75 1.0 0.88 <0.01 0.27 0.69 <0.001 0.47 <0.001 1.0 0.28 0.12 0.42 0.94 0.91 0.04 0.04 <0.001

156 (35.5%) 400 (91.1%) 334 (76.1%) 8 (1.4%)

46 (28.8%) 150 (93.4%) 128 (80.0%) 6 (3.0%)

0.23 0.49 0.58 0.32

62 (10.9%) 3 (0.5%) 4 (0.7%) 7 (1.2%) 39 (6.8%) 28 (4.9%) 7.5 ± 4.5

47 (23.9%) 5 (2.5%) 5 (2.5%) 17 (8.6%) 34 (17.3%) 17 (8.6%) 12.5 ± 10.4

<0.001 0.03 0.053 <0.001 <0.001 0.055 <0.001

Definitions: Obesity, body mass index >=30; Hypertension, diagnosis based on documented history of hypertension treated with medication or documented blood pressure >140 mmHg systolic or >90 mmHg diastolic on at least 2 occasions; Dyslipidemia, diagnosis based on total cholesterol >200 mg/dl, low-density lipoprotein >=130 mg/dl, or high-density lipoprotein <40 mg/dl in men or <50 mg/dl in women; Chronic kidney disease, estimated creatinine clearance <60 (ml/min).

ACCEPTED MANUSCRIPT 1

Table 2: Echocardiographic Parameters

TE D

EP AC C

P-value

RI PT

234 (41.2%) 195 (34.3%) 77 (13.6%) 37 (6.5%) 25 (4.4%) 90.2 ± 24.2 31 (5.4%) 7.1 ± 1.9 7.9 ± 2.1 50.6 ± 8.7 0.32 ± 0.14 35.4 ± 10.2 12 (2.1%)

M AN U

Left atrium volume index (mL/m2) Left ventricular end-diastolic volume index (mL/m2) Left ventricular ejection fraction (%) Left ventricular diastolic function Normal Impaired Pseudonormal Restrictive N/A Left ventricular mass index (g/m2) Moderate/severe mitral regurgitation Right atrial area index (cm2/m2) Right ventricular end-diastolic area index (cm2/m2) Right ventricular fractional area change (%) Right ventricular myocardial performance index Pulmonary artery systolic pressure (mmHg) Moderate/severe tricuspid regurgitation

65 (33.0%) 66 (33.5%) 33 (16.8%) 27 (13.7%) 6 (3.1%) 94.8 ± 23.7 19 (9.6%) 7.6 ± 1.9 8.2 ± 2.3 49.5 ± 10.2 0.37 ± 0.16 39.4 ± 12.3 10 (5.1%)

SC

Variable

Post Operative Atrial Fibrillation No Yes (N=571) (N=197) 28.0 ± 11.4 32.0 ± 11.5 49.2 ± 18.2 55.7 ± 21.1 56.1 ± 12.9 53.7 ± 13.4

<0.001 <0.001 0.03

<0.05 0.87 0.26 <0.01 0.41 0.02 0.04 <0.01 0.09 0.14 <0.001 <0.001 0.03

ACCEPTED MANUSCRIPT 1

Table 3: Optimal Model to Predict Postoperative Atrial Fibrillation Adjusted

95% CI

1.98

Right ventricular myocardial performance index ≥0.4

1.50

Age, per year

1.05

SC

Left atrium volume index ≥34 mL/m2

RI PT

Odds Ratio 1.36 to 2.87

1.01 to 2.24

1.03 to 1.07

AC C

EP

TE D

M AN U

The following variables were entered in the multivariable regression model: age, sex, body mass index, hypertension, chronic kidney disease, chronic lung disease, prior cardiac surgery, left atrial volume index, LV enddiastolic volume index, LV ejection fraction, LV hypertrophy, LV diastolic function, right atrial area, RV end-diastolic area, RV fractional area change, RV myocardial performance index, pulmonary arterial systolic pressure, mitral regurgitation, tricuspid regurgitation.

ACCEPTED MANUSCRIPT 1

Figure 1: Study Flow Chart

RI PT

1386 patients underwent isolated CABG at the two sites

SC

532 did not have a preoperative echocardiogram available

M AN U

854 patients were eligible

TE D

86 had preoperative atrial fibrillation

AC C

EP

768 patients were included